Cargando…
Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis
Multiple reports have claimed that low-dose orally administered interferon (IFN)-α is beneficial in the treatment of many infectious diseases and provides a viable alternative to high-dose intramuscular treatment. However, research is needed on how to express IFN stably in the gut. Bifidobacterium m...
Autores principales: | Yu, Zhijian, Huang, Zhen, Shao, Chongwen, Huang, Yuanjian, Zhang, Fan, Yang, Jin, Deng, Lili, Zeng, Zhongming, Deng, Qiwen, Zeng, Weiseng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248883/ https://www.ncbi.nlm.nih.gov/pubmed/22151967 http://dx.doi.org/10.1186/1743-422X-8-525 |
Ejemplares similares
-
Hepatitis B virus core protein with hot-spot mutations inhibit MxA gene transcription but has no effect on inhibition of virus replication by interferon α
por: Zhijian, Yu, et al.
Publicado: (2010) -
Identification of plasmalogens in Bifidobacterium longum, but not in Bifidobacterium animalis
por: Mawatari, Shiro, et al.
Publicado: (2020) -
Proteomic comparison of the cytosolic proteins of three Bifidobacterium longum human isolates and B. longum NCC2705
por: Aires, Julio, et al.
Publicado: (2010) -
Revisiting the Metabolic Capabilities of Bifidobacterium longum susbp. longum and Bifidobacterium longum subsp. infantis from a Glycoside Hydrolase Perspective
por: Blanco, Guillermo, et al.
Publicado: (2020) -
Expression of CD80 and CD86 on B cells during coxsackievirus B3-induced acute myocarditis
por: HUANG, YANLAN, et al.
Publicado: (2020)